Intracellular lithium and cyclic AMP levels are mutually regulated in neuronal cells

Journal of Neurochemistry

Volumn 90, Issue 4, 2004, Pages 920-930

  Montezinho, L P ^a,b,c   Duarte, C B ^a,c   Fonseca, C P ^a,b,c   Glinka, Y ^d   Layden, B ^d   Mota De Freitas, D ^d   Geraldes, C F G C ^a,b,c   Castro, M M C A ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Calcium; cAMP; Forskolin; Lithium; Na+ Ca2+ exchanger

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; BUCLADESINE; CALCIUM CHANNEL N TYPE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; LITHIUM; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BRAIN LEVEL; DRUG TRANSPORT; DRUG UPTAKE; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; FLUORESCENCE SPECTROSCOPY; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HUMAN CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ADENYLATE CYCLASE; ANIMALS; BUCLADESINE; CALCIUM; CELLS, CULTURED; CYCLIC AMP; FORSKOLIN; HUMANS; INTRACELLULAR FLUID; ION TRANSPORT; LITHIUM; NEUROBLASTOMA; NEURONS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 4143076854     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02551.x     Document Type: Article

References (84)

1. Abajo F. J., Castro M. A., Garijo B. and Sanchez-Garcia P. (1987) Catecholamine release evoked by lithium from the perfused adrenal gland of the cat. Br. J. Pharmacol. 91, 539-546.
2. Ahlijanian M. K., Striessnig J. and Catterall W. A. (1991) Phosphorylation of an alpha 1-like subunit of an omega-conotoxin-sensitive brain calcium channel by cAMP-dependent protein kinase and protein kinase. J. Biol. Chem. 266, 20192-20197.
3. Allison J. H. and Stewart M. A. (1971) Reduced brain inositol in lithium-treated rats. Nat. New Biol. 233, 267-268.
4. 31P NMR study. Biophys. J. 76, 2934-2942.
5. Andersen P. H. and Geisler A. (1984) Lithium inhibition of forskolin-stimulated adenylate cyclase. Neuropsychobiology 12, 1-3.
6. Avissar S., Schreiber G., Danon A. and Belmaker R. H. (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331, 440-442.
7. +)-ATPase. Biochim. Biophys. Acta 527, 472-484.
8. Bender J. L. and Neer E. J. (1983) Properties of the adenylate cyclase catalytic unit from caudate nucleus. J. Biol. Chem. 258, 2432-2439.
9. Brewer G. J., Torricelli J. R., Evege E. K. and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
10. Brunello N. and Tascedda F. (2003) Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int. J. Neuropsychopharmacol. 6, 181-189.
11. Busch S., Burckhardt B. C. and Siffert W. (1995) Expression of the human sodium/proton exchanger NHE-1 in Xenopus laevis oocytes enhances sodium/proton exchange activity and establishes sodium/lithium countertransport. Pflugers Arch. 429, 859-869.
12. Carli M., Anand-Srivastava M. B., Molina-Holgado E., Dewar K. M. and Reader T. A. (1994) Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem. Int. 24, 13-22.
13. Chang A., Li P. P. and Warsh J. J. (2003) Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. J. Neurochem. 84, 781-791.
14. Corry B., Allen T. W., Kuyucak S. and Chung S. H. (2001) Mechanisms of permeation and selectivity in calcium channels. Biophys. J. 80, 195-214.
15. 2+ in single chromaffin cells. Eur. J. Pharmacol. 306, 219-226.
16. 2+ exchange activity in rat skeletal myotubes: effect of lithium ions. Cell Calcium 31, 37-44.
17. Dousa T. and Hechter O. (1970) Lithium and brain adenylyl cyclase. Lancet 1, 834-835.
18. Ebstein R. P., Hermoni M. and Belmaker R. H. (1980) The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J. Pharmacol. Exp. Ther. 213, 161-167.
19. Ehrlich B. E. and Diamond J. M. (1980) Lithium, membranes, and manic-depressive illness. J. Membr. Biol. 52, 187-200.
20. Emamghoreishi M., Li P. P., Schlichter L., Parikh S. V., Cooke R. and Warsh J. J. (2000) Associated disturbances in calcium homeostasis and G protein-mediated cAMP signalling in bipolar I disorder. Biol. Psychiatry 48, 665-673.
21. 2+ competition in bovine chromafin cells. BBA Mol. Cell Res. 1691, 79-90.
22. Forsythe I. D., Lambert D. G., Nahorski S. R. and Lindsdell P. (1992) Elevation of cytosolic calcium by cholinoceptor agonists in SH-SY5Y human neuroblastoma cells: estimation of the contribution of voltage-dependent currents. Br. J. Pharmacol. 107, 207-214.
23. Frausto da Silva J. J. and Williams R. J. (1976) Possible mechanism for the biological action of lithium. Nature 263, 237-239.
24. Friedman E. and Wang H. Y. (1996) Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 67, 1145-1152.
25. Goodwin F. K. and Jamison K. R. (1990) Manic-Depressive Illness. New York: Oxford University Press.
26. Gross R. A., Moises H. C., Uhler M. D. and Macdonald R. L. (1990) Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc. Natl Acad. Sci. USA 87, 7025-7029.
27. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
28. Hallcher L. M. and Sherman W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901.
29. Hertz E., Yua C. H., Hertz L., Jurlink B. H. J. and Schousboe A. (1989) Preparation of primary cultures of mouse cortical neurons, in A Dissection and Tissue Culture Manual of the Nervous System (Shahar, A., de Vellis, J., Vemadakis, A. and Haber, B., eds). Alan R. Liss, New York.
30. 2+ channels in rat brain regions and cultured neuronal cells. Neurosci. Lett. 223, 169-172.
31. Holl R. W., Thomer M. O. and Leong D. A. (1989) Cytosolic free calcium in normal somatotropes: effects of forskolin and phorbol ester. Am. J. Physiol. 256, E375-E379.
32. 2+-signalling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1. J. Biol. Chem. 270, 17749-17757.
33. Ikeda A. and Kato T. (2003) Biological predictors of lithium response in bipolar disorder. Psychiatry Clin. Neurosci. 57, 243-250.
34. 2+ exchange in cells expressing NCX1. J. Biol. Chem. 271, 22391-22397.
35. Jang I. S. and Juhnn Y. S. (2001) Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsα. Exp. Mol. Med. 33, 37-45.
36. Jope R. S. (1999a) Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128.
37. Jope R. S. (1999b) A bimodal model of the mechanism of action of lithium. Mol. Psychiatry 4, 21-25.
38. Jope R. S. (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441-443.
39. +-dependent manner. Endocrinology 143, 4210-4217.
40. Kato M., Ma H. T. and Tatemoto K. (1996) GLP-1 depolarizes the rat pancreatic beta cell in a Na+-dependent manner. Regul. Pept. 62, 23-27.
41. Lakey T., Mac N. S., Humphries H., Walker S. W., Munro D. S. and Tomlinson S. (1985) Calcium and calmodulin in the regulation of human thyroid adenylate cyclase activity. Biochem. J. 225, 581-589.
42. 2+ entry induced by depolarization and muscarinic receptor stimulation in SH-SY5Y human neuroblastoma cells. Brain Res. Mol. Brain Res. 8, 263-266.
43. 2+ competition at therapeutic intracellular Li+ levels in human neuroblastoma SH-SY5Y cells. Bipolar Disord. 2, 200-204.
44. 2+ competition in cells: implications for bipolar disorder. Biochem. Pharmacol. 66, 1915-1924.
45. 2+-sensitive nonselective cation channels in regulating the membrane potential of pancreatic beta-cells. Diabetes 47, 1066-1073.
46. Manji H. K. (1992) G proteins: implications for psychiatry. Am. J. Psychiatry 149, 746-760.
47. Manji H. K., Potter W. Z. and Lenox R. H. (1995) Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry 52, 531-543.
48. Masana M. I., Bitran J. A., Hsiao J. K., Mefford I. N. and Potter W. Z. (1991) Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study. Brain Res. 538, 333-336.
49. i modulation of adenylate cyclase in brain. J. Neurochem. 59, 200-205.
50. 2+ exchanger: physiology and pharmacology. Jpn. J. Pharmacol. 74, 1-20.
51. 2+ currents in rat thalamocortical relay neurons by activity and phosphorylation. Eur. J. Neurosci. 15, 1603-1614.
52. i associated with insulin secretion in pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 285, E1001-E1009.
53. Mørk A. and Geisler A. (1987a) Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain. Pharmacol. Toxicol. 60, 241-248.
54. Mørk A. and Geisler A. (1987b) Effects of lithium on calmodulin-stimulated adenylate cyclase activity in cortical membranes from rat brain. Pharmacol Toxicol. 60, 17-23.
55. Mørk A. and Geisler A. (1989a) Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylate cyclase activity in rat brain. Eur. J. Pharmacol. 168, 347-354.
56. Mørk A. and Geisler A. (1989b) The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology 28, 307-311.
57. Mørk A. and Geisler A. (1989c) Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol. Psychiatry 26, 279-288.
58. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
59. 2+ for the phosphate groups in the human erythrocyte membrane and ATP: an NMR and fluorescence study. Biochemistry 33, 4101-4110.
60. 3H]-noradrenaline release in the human neuroblastoma SH-SY5Y. Neurochem. Res. 25, 385-387.
61. Newman M. E. and Belmaker R. H. (1987) Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology 26, 211-217.
62. Newman M. E., Drummer D. and Lerer B. (1990) Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain. J. Pharmacol. Exp. Ther. 252, 826-831.
63. + properties in neuroblastoma SH-SY5Y cells. J. Neurochem. 71, 1676-1684.
64. Pandey G. N., Sarkadi B., Haas M., Gunn R. B., Davis J. M. and Tosteson D. C. (1978) Lithium transport pathways in human red blood cells. J. Gen. Physiol. 72, 233-247.
65. 31P NMR and optical spectroscopy study. FEBS Lett. 244, 223-226.
66. Reeve H. L., Vaughan P. F. and Peers C. (1994) Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and omega-conotoxin. Eur. J. Neurosci. 6, 943-952.
67. Reeves M. L., Leigh B. K. and England P. J. (1987) The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J. 241, 535-541.
68. Reuveny E. and Narahashi T. (1993) Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells. Brain Res. 603, 64-73.
69. Ryves W. J. and Harwood A. J. (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280, 720-725.
70. Sarkadi B., Alifimoff J. K., Gunn R. B. and Tosteson D. C. (1978) Kinetics and stoichiometry of Na-dependent Li transport in human red blood cells. J. Gen. Physiol. 72, 249-265.
71. Scott J. D. (1991) Cyclic nucleotide-dependent protein kinases. Pharmacol. Ther. 50, 123-145.
72. Seamon K. B. and Daly J. W. (1981) Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256, 9799-9801.
73. Seward E. P. and Henderson G. (1990) Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells. Pflugers Arch. 417, 223-230.
74. Skalhegg B. S. and Tasken K. (2000) Specificity in the cAMP/PKA signalling pathway: differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci. 5, D678-D693.
75. Smith D. F. (1990) Effects of lithium and rolipram enantiomers on locomotor activity in inbred mice. Pharmacol. Toxicol. 66, 142-145.
76. Spaulding S. W. (1993) The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr. Rev. 14, 632-650.
77. Stubbs E. B. Jr. and Agranoff B. W. (1993) Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositol-depleted SK-N-SH neuroblastoma cells. J. Neurochem. 60, 1292-1299.
78. Sulakhe P. V. and Hoehn E. K. (1984) Interaction of EGTA with a hydrophobic region inhibits particulate adenylate cyclase from rat cerebral cortex: a study of an EGTA-inhibitable enzyme by using alamethicin. Int. J. Biochem. 16, 1029-1035.
79. Takano K., Takei T., Teramoto A. and Yamashita N. (1996) GHRH activates a nonselective cation current in human GH-secreting adenoma cells. Am. J. Physiol. 270, E1050-E1057.
80. Tang W. J., Kuprinski J. and Gilman A. G. (1991) Expression and characterization of calmodulin-activated (type I) adenylyl-cyclase. J. Biol. Chem. 266, 8595-8603.
81. Walaas S. I. and Greengard P. (1991) Protein phosphorylation and neuronal function. Pharmacol. Rev. 43, 299-349.
82. Williams R. S. and Harwood A. J. (2000) Lithium therapy and signal transduction. Trends Pharmacol. Sci. 21, 61-64.
83. Xiong W., Moore H. M., Howlett S. E. and Ferrier G. R. (2001) In contrast to forskolin and 3-isobutyl-l-methylxanthine, amrinone stimulates the cardiac voltage-sensitive release mechanism without increasing calcium-induced calcium release. J. Pharmacol. Exp. Ther. 298, 954-963.
84. s alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61, 890-898.